Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
eNq1mFFP2zAQx9/7KaK8N2lpgDClRVsHWyXQukK1aS/ITa7UXbDTsx3KPv2cpmxlcga4+DFx8r+L7+/fnZKcru9yrwQUlLO+3w06vgcs5Rllt31/en3ejv3TQStZkpLsPHYcdILuge+lORGi71erwQwIE8H3y4uPoN8H9ActL+GzJaTyyXNK0jz4TMTikhTVM15Scpp5dyAXPOv7hZKbu14iJOosBvccf4qCpJCE2zu7q8ubaPd+ElZiL1BVAvCCsFuj6BytNFOFCEwOiYRbjg9m6fTmID4+6nRiqxBUTEBwhSmMiVyMkZc0g8wcieQCrILM77MrwDIHWQUxiofL9E5YiZMlWU9gNTIn/V6vDuVatjvt7vFRfBh1e4dRFB1YhcKdrTKbR39EWNz0oqh30jkJ5xiuVElLumpnBGnGEdaESctCjTlKkjsqERXDp2ZzFAdh9awVMiqKnDwES1HYbhVBopcBNRLcfUj1BdeoIZXrPftHn6k8D1+Z9XSLEEcZV4QacsVkA0nOJ7YbMeRMwrq5onbwk+utFymIt5P9xZkZ/GM1y2lqyzdNIAVCTiejZrw5I8MHImCK7tDwjbKM34u3R85uiR1lX2yo+Z/WGcVxbH2efmg3NXSeM4W8gFCjiIp9CDNic74vW7RBzVKP9nTjzM1MxFOSQ8NU1LZkjrbk4xDnzPTuDlS9YBT9dHZt65WvCvDhanNplKZZ/0+V7YDsgvLamY2Jv97n9WF/wbwcxT27EVChmSULKQvxLgwXRLSFPi8Q6IPkFPo7Tdfd2O6ks9eTTo1OR6nP6o748lLZnrrn+v6+s+z2/e3MbIwhUcEedagB7Qyjo7O3J/PfQdZZ2uMnJHEXZjN0Ekk5czX/qJlRcb9eoOvKzlHD4ct8Thv+pDT6MgnrvziDVhJWf3AGrd/1F/oC
cWy4bygNACA3Fxqh